Smoking Cessation Therapy Area Pipeline ReportLife Science Analytics (LSA)March 14, 2011 141 Pages - SKU: LSA6237325 |
| Life Science Analytics', Smoking Cessation Therapy Area Pipeline Report contains detailed information on the smoking cessation drug pipeline. This report provides insight into the pipeline status of smoking cessation drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date. In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area. Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products. Key benefits
|
Related Markets
Smoking Cessation Reports
- The World Market for Over The Counter (OTC) Drugs
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Smoking Addiction Global Clinical Trials Review, Q2, 2011
- Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
- Nicotine Addiction Global Clinical Trials Review, Q1, 2011
